Dopexamine

DB12313ApprovedWithdrawnSmall molecule

Dopexamine has been used in trials studying the diagnostic and treatment of Free Flap, Oral Cancer, Hypotension, Septic Shock, and Head and Neck Cancer.

Chemical structure of Dopexamine
Formula / weight
C22H32N2O2 · 356.5017 g/mol (avg)
Code names
FPL-60278

Resolves to

Compound
UNII398E7Z7JB5CAS86197-47-9ChEMBLCHEMBL77622ChEBI135507PubChem55483
Clinical / RWD
RxNorm23638ATCC01CA14
Structure
InChIKeyRYBJORHCUPVNMB-UHFFFAOYSA-NSMILESOC1=C(O)C=C(CCNCCCCCCNCCC2=CC=CC=C2)C=C1
Targets
P14416DRD2

What you can answer from here — as of September 16, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
729Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Marketed productAcross 1 country and 1 labeller
Sign in
1ATC codeIncluding every combination product, plus 21 drug categories
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Dopexamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In